'Promising' oral antiviral drug vs COVID-19 now on Phase 3 clinical trial at Lung Center

'Promising' oral antiviral drug vs COVID-19 now on Phase 3 clinical trial at Lung Center

Opis bibliograficzny
Wydane w:Manila Bulletin Vol. 584, no. 7 (07 Aug. 2021), 2
1. autor: Luci, Charissa M.
Format: Artykuł
Wydane: 2021
Hasła przedmiotowe:
Molnupiravir (Antiviral drug)
Clinical trials > Lung Center of the Philippines
COVID-19 treatment